CStone appoints three distinguished oncology leaders Drs. Paul A. Bunn, Jr., Elizabeth M. Jaffee and Richard S. Finn to its Scientific Advisory Board

March 25, 2019   |   March 2019 Bond Updates
SHANGHAI, March 25, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) is pleased to announce the appointment of three internationally renowned oncologists Paul A. Bunn, Jr., MD, Elizabeth M. Jaffee, MD, and Richard S. Finn, MD, as the company's Scientific Advisory Board...

View more at: https://www.prnewswire.com:443/news-releases/cstone-appoints-three-distinguished-oncology-leaders-drs-paul-a-bunn-jr-elizabeth-m-jaffee-and-richard-s-finn-to-its-scientific-advisory-board-300817542.html
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/